153 related articles for article (PubMed ID: 36894753)
1. Exploratory analysis of mesenteric-portal axis CT radiomic features for survival prediction of patients with pancreatic ductal adenocarcinoma.
Rigiroli F; Hoye J; Lerebours R; Lyu P; Lafata KJ; Zhang AR; Erkanli A; Mettu NB; Morgan DE; Samei E; Marin D
Eur Radiol; 2023 Aug; 33(8):5779-5791. PubMed ID: 36894753
[TBL] [Abstract][Full Text] [Related]
2. CT Radiomic Features of Superior Mesenteric Artery Involvement in Pancreatic Ductal Adenocarcinoma: A Pilot Study.
Rigiroli F; Hoye J; Lerebours R; Lafata KJ; Li C; Meyer M; Lyu P; Ding Y; Schwartz FR; Mettu NB; Zani S; Luo S; Morgan DE; Samei E; Marin D
Radiology; 2021 Dec; 301(3):610-622. PubMed ID: 34491129
[TBL] [Abstract][Full Text] [Related]
3. Radiomic feature reproducibility in contrast-enhanced CT of the pancreas is affected by variabilities in scan parameters and manual segmentation.
Yamashita R; Perrin T; Chakraborty J; Chou JF; Horvat N; Koszalka MA; Midya A; Gonen M; Allen P; Jarnagin WR; Simpson AL; Do RKG
Eur Radiol; 2020 Jan; 30(1):195-205. PubMed ID: 31392481
[TBL] [Abstract][Full Text] [Related]
4. Validation of Prognostic Radiomic Features From Resectable Pancreatic Ductal Adenocarcinoma in Patients With Advanced Disease Undergoing Chemotherapy.
Salinas-Miranda E; Khalvati F; Namdar K; Deniffel D; Dong X; Abbas E; Wilson JM; O'Kane GM; Knox J; Gallinger S; Haider MA
Can Assoc Radiol J; 2021 Nov; 72(4):605-613. PubMed ID: 33151087
[TBL] [Abstract][Full Text] [Related]
5. CT texture analysis for the presurgical prediction of superior mesenteric-portal vein invasion in pancreatic ductal adenocarcinoma: comparison with CT imaging features.
Chen F; Zhou Y; Qi X; Xia W; Zhang R; Zhang J; Gao X; Zhang L
Clin Radiol; 2021 May; 76(5):358-366. PubMed ID: 33581837
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of CT Radiomic Features in Resectable Pancreatic Ductal Adenocarcinoma.
Khalvati F; Zhang Y; Baig S; Lobo-Mueller EM; Karanicolas P; Gallinger S; Haider MA
Sci Rep; 2019 Apr; 9(1):5449. PubMed ID: 30931954
[TBL] [Abstract][Full Text] [Related]
7. Radiomics model-based algorithm for preoperative prediction of pancreatic ductal adenocarcinoma grade.
Tikhonova VS; Karmazanovsky GG; Kondratyev EV; Gruzdev IS; Mikhaylyuk KA; Sinelnikov MY; Revishvili AS
Eur Radiol; 2023 Feb; 33(2):1152-1161. PubMed ID: 35986774
[TBL] [Abstract][Full Text] [Related]
8. A CT Radiomics-Based Risk Score for Preoperative Estimation of Intraoperative Superior Mesenteric-Portal Vein Involvement in Pancreatic Ductal Adenocarcinoma.
Zhou Y; Wang J; Zhang SL; Wang H; Yan Y; Qi X; Chen S; Chen FM
Ann Surg Oncol; 2023 Feb; 30(2):1206-1216. PubMed ID: 36264518
[TBL] [Abstract][Full Text] [Related]
9. Preoperative CT predictors of survival in patients with pancreatic ductal adenocarcinoma undergoing curative intent surgery.
Dickinson SM; McIntyre CA; Schilsky JB; Harrington KA; Gerst SR; Flynn JR; Gonen M; Capanu M; Wong W; Lawrence S; Allen PJ; O'Reilly EM; Jarnagin WR; D'Angelica MI; Balachandran VP; Drebin JA; Kingham TP; Simpson AL; Do RK
Abdom Radiol (NY); 2021 Apr; 46(4):1607-1617. PubMed ID: 32986175
[TBL] [Abstract][Full Text] [Related]
10. Assessment of Response to Neoadjuvant Therapy Using CT Texture Analysis in Patients With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma.
Borhani AA; Dewan R; Furlan A; Seiser N; Zureikat AH; Singhi AD; Boone B; Bahary N; Hogg ME; Lotze M; Zeh HJ; Tublin ME
AJR Am J Roentgenol; 2020 Feb; 214(2):362-369. PubMed ID: 31799875
[No Abstract] [Full Text] [Related]
11. Radiological prediction of portal vein infiltration in patients with pancreatic ductal adenocarcinoma.
Lapshyn H; Schulte T; Sondermann S; May K; Petrova E; Honselmann KC; Braun R; Zemskov S; Keck T; Wellner UF; Bausch D; Bolm L
Pancreatology; 2021 Jan; 21(1):155-162. PubMed ID: 33309623
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological correlation of radiologic measurement of post-therapy tumor size and tumor volume for pancreatic ductal adenocarcinoma.
Wei D; Zaid MM; Katz MH; Prakash LR; Kim M; Tzeng CD; Lee JE; Agrawal A; Rashid A; Wang H; Varadhachary G; Wolff RA; Tamm EP; Bhosale PR; Maitra A; Koay EJ; Wang H
Pancreatology; 2021 Jan; 21(1):200-207. PubMed ID: 33221151
[TBL] [Abstract][Full Text] [Related]
13. Borderline Resectable and Locally Advanced Pancreatic Cancer: FDG PET/MRI and CT Tumor Metrics for Assessment of Pathologic Response to Neoadjuvant Therapy and Prediction of Survival.
Panda A; Garg I; Truty MJ; Kline TL; Johnson MP; Ehman EC; Suman G; Anaam DA; Kemp BJ; Johnson GB; Halfdanarson TR; Venkatesh SK; Fidler JL; Goenka AH
AJR Am J Roentgenol; 2021 Sep; 217(3):730-740. PubMed ID: 33084382
[No Abstract] [Full Text] [Related]
14. CT radiomics associations with genotype and stromal content in pancreatic ductal adenocarcinoma.
Attiyeh MA; Chakraborty J; McIntyre CA; Kappagantula R; Chou Y; Askan G; Seier K; Gonen M; Basturk O; Balachandran VP; Kingham TP; D'Angelica MI; Drebin JA; Jarnagin WR; Allen PJ; Iacobuzio-Donahue CA; Simpson AL; Do RK
Abdom Radiol (NY); 2019 Sep; 44(9):3148-3157. PubMed ID: 31243486
[TBL] [Abstract][Full Text] [Related]
15. Radiomics-based Machine-learning Models Can Detect Pancreatic Cancer on Prediagnostic Computed Tomography Scans at a Substantial Lead Time Before Clinical Diagnosis.
Mukherjee S; Patra A; Khasawneh H; Korfiatis P; Rajamohan N; Suman G; Majumder S; Panda A; Johnson MP; Larson NB; Wright DE; Kline TL; Fletcher JG; Chari ST; Goenka AH
Gastroenterology; 2022 Nov; 163(5):1435-1446.e3. PubMed ID: 35788343
[TBL] [Abstract][Full Text] [Related]
16. Clinical Features and Computed Tomography Radiomics-Based Model for Predicting Pancreatic Ductal Adenocarcinoma and Focal Mass-Forming Pancreatitis.
Ye Y; Zhang J; Song P; Qin P; Hu Y; An P; Li X; Lin Y; Wang J; Feng G
Technol Cancer Res Treat; 2023; 22():15330338231180792. PubMed ID: 37287274
[No Abstract] [Full Text] [Related]
17. Correlation of transcriptional subtypes with a validated CT radiomics score in resectable pancreatic ductal adenocarcinoma.
Salinas-Miranda E; Healy GM; Grünwald B; Jain R; Deniffel D; O'Kane GM; Grant R; Wilson J; Knox J; Gallinger S; Fischer S; Khokha R; Haider MA
Eur Radiol; 2022 Oct; 32(10):6712-6722. PubMed ID: 36006427
[TBL] [Abstract][Full Text] [Related]
18. Complementary role of computed tomography texture analysis for differentiation of pancreatic ductal adenocarcinoma from pancreatic neuroendocrine tumors in the portal-venous enhancement phase.
Reinert CP; Baumgartner K; Hepp T; Bitzer M; Horger M
Abdom Radiol (NY); 2020 Mar; 45(3):750-758. PubMed ID: 31953587
[TBL] [Abstract][Full Text] [Related]
19. CT Radiomics-Based Preoperative Survival Prediction in Patients With Pancreatic Ductal Adenocarcinoma.
Park S; Sham JG; Kawamoto S; Blair AB; Rozich N; Fouladi DF; Shayesteh S; Hruban RH; He J; Wolfgang CL; Yuille AL; Fishman EK; Chu LC
AJR Am J Roentgenol; 2021 Nov; 217(5):1104-1112. PubMed ID: 34467768
[No Abstract] [Full Text] [Related]
20. Radiomic Features at CT Can Distinguish Pancreatic Cancer from Noncancerous Pancreas.
Chen PT; Chang D; Yen H; Liu KL; Huang SY; Roth H; Wu MS; Liao WC; Wang W
Radiol Imaging Cancer; 2021 Jul; 3(4):e210010. PubMed ID: 34241550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]